Key Findings
The India irritable bowel syndrome treatment market is registered to record a CAGR of 11.64%, across the forecast period. The depletion of potable drinking water, the lack of proper sanitation, and the increased prevalence of irritable bowel syndrome are expected to propel the country’s market growth. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2026.

Market Insights
According to a 2018 article, the incidence of irritable bowel syndrome (IBS) within the Indian community, ranges from 10% to 20%. Although sexual function, psychiatric disorders, pelvic pain, work absenteeism, and gastroesophageal reflux diseases were ideally associated with irritable bowel syndrome in the country, marital status, sex, socioeconomic status, and religion, were not.
In addition to the aspects mentioned earlier, the depletion of potable drinking water and adequate sanitation further leads to disorders of the digestive system. They are also among the major causes of most water-borne diseases and digestive disorders. Moreover, India’s surging geriatric population plays an essential role in augmenting the market growth, as well. For instance, as per the Population Census, nearly 104 million elderly individuals, aged 60 and above, live in the country. Therefore, these factors are expected to fuel the irritable bowel syndrome treatment market growth in India during the forecast period.

Competitive Insights
Some of the leading companies operating in the market are, Novartis AG, Abbott Laboratories, Allergan PLC, AstraZeneca PLC, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments